Wasatch Advisors Inc Opti Nose, Inc. Transaction History

Wasatch Advisors Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.35 - $3.16 $1.82 Million - $2.44 Million	-773,196 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$2.91 - $3.83 $6,044 - $7,954	2,077 Added 0.27%	773,196 $2.41 Million
Q1 2021 May 10, 2021	BUY	$3.47 - $4.75 $37,104 - $50,791	10,693 Added 1.41%	771,119 $2.85 Million
Q3 2020 Nov 10, 2020	SELL	$3.69 - $7.09 $622,709 - $1.2 Million	-168,756 Reduced 18.16%	760,426 $2.97 Million
Q2 2020 Aug 12, 2020	SELL	$3.58 - $7.44 $953,780 - $1.98 Million	-266,419 Reduced 22.28%	929,182 $6.91 Million
Q1 2020 May 08, 2020	BUY	$3.49 - $9.2 $304,760 - $803,380	87,324 Added 7.88%	1,195,601 $5.37 Million
Q4 2019 Feb 13, 2020	BUY	$6.27 - $11.41 $2.46 Million - $4.48 Million	392,302 Added 54.79%	1,108,277 $10.2 Million
Q3 2019 Nov 14, 2019	BUY	$4.75 - $8.38 $216,647 - $382,211	45,610 Added 6.8%	715,975 $5.01 Million
Q2 2019 Aug 07, 2019	BUY	$6.4 - $10.94 $4.29 Million - $7.33 Million	670,365 New	670,365 $0

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $40M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Wasatch Advisors Inc with notifications on news.